跳到正文
Endpoints News· Max Bayer·· 2 小时前AI 评分22

Bristol Myers 为管线辩护,重申对后期阶段 BD 的兴趣

Bristol Myers defends pipeline, reinforces later stage BD interest

AI 导读

Bristol Myers Squibb 在财报电话会上重申其抵御行业最严峻专利悬崖之一的计划,并为管线辩护。公司同时强调对后期阶段业务拓展(BD)的兴趣。

正文 · 原文

Bris­tol My­ers Squibb is re-em­pha­siz­ing its plan to stave off one of the in­dus­try’s most daunt­ing patent cliffs.

Speak­ing to an­a­lysts on its earn­ings call …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News · endpoints.news

AI 摘要声明:站内标题、摘要与推荐理由由模型基于公开来源生成,属机器生成内容,非原文;本页内容仅供医药行业信息参考,不构成医疗建议、诊断或用药依据。